Antibody Catalyzed Water Oxidation Pathway Biosensor
Infectious diseases, such as influenza, present a significant global challenge through the constant threat of pandemics. We report the development of a novel biosensor that can be functionalized to address a wide range of infectious diseases. This biosensor is based on the electrochemical detection of hydrogen peroxide generated through the intrinsic catalytic activity of all antibodies: the Antibody Catalyzed Water Oxidation Pathway (ACWOP). Our biosensor platform includes a polymer brush-modified surface where antibodies bind to a conjugated small molecule, or hapten, that is capable of eliciting an immune response. The antibody produced hydrogen peroxide supplies the electrochemical signal mediated by Resorufin/Amplex Red. We demonstrate the complete function of the biosensor platform using anti-2,4-dinitrophenyl (anti-DNP) antibodies as a model system. Currently, the standard method for antibody detection is based on the enzyme-linked immunosorbent assay (ELISA) which requires labeled secondary reagents to bind antibodies, as well as multiple procedural steps. Thus, the ultimate goal of the biosensor described here will involve preparing an inexpensive device that is portable, reliable, and fast.
Diane Cook
Faculty: Project PI
What confounds, if any, exist that could cause the biosensor to report
false positives or false negatives?
David Calabrese
Graduate Student
While we have not observed a false positive or negative, likely sources could be an uncharacteristically high concentration of hydrogen peroxide or a radical inhibitor already present in the sample. Depending on the sample, it may be possible that other biological material may interfere with our detection of hydrogen peroxide, but we have found nothing to suggest that that might happen.
Julia Hirschberg
Faculty: Project PI
What are the limitations/weaknesses of your proposed technique?
Devin Wakefield
Thank you Julia for your question.
A limitation with our technique may include the fact that extended exposure to UV light is needed for optimal singlet oxygen production. We have currently tested irradiation for 60 minutes and have found that longer times can result in a signal decrease and an increase in background, possibly due to UV damage of bound antibodies. However, we have been using a wide benchtop UV light source. It may be likely that a more concentrated light source could serve to shorten this temporal requirement while minimizing any antibody damage.
Other weaknesses are currently in the necessity of intermediates and additional reagents, like Amplex Red, for the detection of antibody produced hydrogen peroxide. For a field ready and portable biosensor device, it may be important to consider alternative detection schemes. Yet, the Amplex Red assay has been widely tested as a highly specific and sensitive measure of hydrogen peroxide concentrations. Also, the Resorufin product from this assay is very stable, allowing quantification of hydrogen peroxide in both oxidative and reductive conditions. Combining the Amplex Red assay with square wave voltammetry in our biosesnor, low hydrogen peroxide concentrations are currently detectable with high fidelity.
Mostafa Bassiouni
Faculty: Project Co-PI
Does your biosensor need to be adapted or configured to work properly in different environments? For example, does the very high temperature in a remote village in Africa prevent the application of your biosensor in field disease studies? Does the small age of the patient hamper detecting infection in newly born infants?
David Calabrese
Graduate Student
Thank you for your question.
Higher temperatures would promote a faster production of hydrogen peroxide while allowing for a larger signal from bound antibodies. Conversely, colder temperatures would generate a lower signal but still allow for sensitive detection. It is possible to modify the polymer brushes with other small molecules for a wider range of antibody binding. In addition, the samples would all be at a temperature of approximately 37 degrees Celcius regardless of different environments.
Small age should not be a problem for our biosensor as it uses only a minimal sample volume to be able to detect picogram quantities of the antibody.
Mary Kathryn Cowles
Faculty: Project PI
How do the sensitivity and specificity of your biosensor compare to those of standard ELISA techniques?
Devin Wakefield
Thank you Dr. Cowles for your question.
Our biosensor compares quite favorably with standard ELISA techniques. Current tests demonstrate that hydrogen peroxide at concentrations as low as 0.33 nM can be measured. Antibodies bound at ~ 5 × 10^-12 mol/cm^2 produce over 25 × 10^-10 mol H2O2/cm^2, which translates to above 250 mM of hydrogen peroxide generated from only 10 µL of a test sample. Stated another way, these results indicate that below 3 picograms of bound antibody may be detected from a 10 µL sample, which equates to an antibody concentration of just 2 pM.
Further, standard ELISA techniques rely on large solid supports (typically a microtiter plate) for immobilizing hapten molecules with either non-specific adsorption or by specifically capturing hapten via surface coated antibodies. Our biosensor, on the other hand, avoids challenges with these approaches by using a smaller surface area by comparison, for the presentation of sufficiently high densities of covalently attached hapten (e.g. DNP) to polymer brushes. Enhanced specificity with our biosensor comes through the capability of modifying these brushes to present a wide range of antibody haptens. Additionally, the polymer brush OEG moieties resist non-specific binding and have long-term stability as a result of their high packing characteristics. We have incubated non-specific antibodies on our DNP capped brushes and photosensitizer surfaces and have found no significant change in frequency as detected by QCM measurements, confirming that non-specific antibodies do not bind to the polymer brushes.